Related Experiment Videos
Penicillin tolerant group A streptococci
Abstract:
A penicillin (PCN) tolerant [minimal inhibitory concentration (MIC) less than or equal to 0.02, minimal bactericidal concentration (MBC) = 3.10 micrograms/ml] group A streptococcus (GAS) was recovered from the bone aspirate of a child with osteomyelitis. The penicillin therapy with 200,000 micron/kg X day, and subsequently ampicillin 360 mg/kg X day, resulting in a serum ampicillin concentration of 74 micrograms/ml, failed to achieve a serum bactericidal effect greater than 1:2. Ninety-nine additional isolates of GAS obtained from 99 infants and children with pharyngitis were randomly selected for study. Organisms were screened for tolerance by macrobroth dilution determination at 0.05 and 1.0 microgram/ml of penicillin. Twenty-two of 100 organisms had MICs = 0.05 microgram/ml and MBCs = 1.0 microgram/ml; further tests were performed on these organisms. Twenty of the 22 strains (20% of all GAS) grown in Mueller-Hinton broth with 2% sheep blood were tolerant to penicillin at 24 hr, with MICs less than or equal to 0.02 and MBCs = 0.39 microgram/ml. When retested at 48 hr the MBCs of the 20 tolerant strains had decreased: three strains by twofold, three strains by fourfold, four strains by eightfold, one strain by 16-fold, and nine strains by 40-fold or greater. Seven strains were not tolerant after 48 hr of incubation. The detection of tolerance was media dependent; only nine strains were tolerant when grown in Todd-Hewitt broth. Tolerance to GAS was more frequent than generally suspected. The phenomenon of tolerance, and potentially delayed killing may alter prophylaxis and therapy of GAS disease and merits further investigation.
Insights
Penicillin-tolerant Group A Streptococcus (GAS) strains were identified in a child with osteomyelitis and in healthy infants. This tolerance, which can be media-dependent, may impact treatment strategies for GAS infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Group A Streptococcus (GAS) is a significant human pathogen.
- Penicillin tolerance in GAS, characterized by a significant difference between minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC), is not well understood.
- Antibiotic tolerance can impact treatment efficacy.
Observation:
- A child with osteomyelitis presented with a penicillin-tolerant GAS isolate.
- Penicillin and ampicillin therapies failed to achieve a sufficient serum bactericidal effect in this patient.
- Screening of 99 additional GAS isolates revealed that 20% exhibited penicillin tolerance under specific laboratory conditions (Mueller-Hinton broth with 2% sheep blood).
Findings:
- Penicillin tolerance in GAS was found to be media-dependent, with fewer strains showing tolerance in Todd-Hewitt broth compared to Mueller-Hinton broth.
- The minimal bactericidal concentration (MBC) for tolerant strains decreased over a 48-hour incubation period, indicating a potential for delayed bacterial killing.
- Tolerance to penicillin in GAS appears to be more prevalent than previously assumed.
Implications:
- The presence of penicillin-tolerant GAS strains may necessitate adjustments in antibiotic prophylaxis and therapeutic regimens.
- Further research is warranted to fully understand the clinical significance of GAS tolerance and its impact on treatment outcomes.
- Investigating the mechanisms behind GAS tolerance could lead to the development of more effective treatment strategies.